Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival

Gastrointestinal Endoscopy

Volumn 72, Issue 1, 2010, Pages 33-43

  Yeh, Jennifer M ^a   Ho, Wendy ^a   Hur, Chin ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH ULCER; AFTERCARE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MIDDLE AGED; PATHOLOGY; PROBABILITY; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; STOMACH NEOPLASMS; SURVIVAL RATE;

AFTERCARE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS; STOMACH NEOPLASMS; STOMACH ULCER; SURVIVAL RATE;

EID: 77954063830     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.01.047     Document Type: Article

References (34)

1. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Version 2.0 (2004), IARC Press, Lyon, France
2. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1975-2000 (2007). http://seer.cancer.gov/csr/1975_2005/ Accessed January 29, 2009
3. Bustamante M., Devesa F., Borghol A., et al. Accuracy of the initial endoscopic diagnosis in the discrimination of gastric ulcers: is endoscopic follow-up study always needed?. J Clin Gastroenterol 35 (2002) 25-28
4. Thomopoulos K.C., Melachrinou M.P., Mimidis K.P., et al. Gastric ulcers and risk for cancer: is follow-up necessary for all gastric ulcers?. Int J Clin Pract 58 (2004 Jul) 675-677
5. Hosokawa O., Watanabe K., Hatorri M., et al. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy 33 (2001) 301-305
6. Pruitt R.E., and Truss C.D. Endoscopy, gastric ulcer, and gastric cancer: follow-up endoscopy for all gastric ulcers?. Dig Dis Sci 38 (1993) 284-288
7. Eckardt V.F., Giessler W., Kanzler G., et al. Does endoscopic follow-up improve the outcome of patients with benign gastric ulcers and gastric cancer?. Cancer 69 (1992) 301-305
8. Podolsky I., Storms P.R., Richardson C.T., et al. Gastric adenocarcinoma masquerading endoscopically as benign gastric ulcer: a five-year experience. Dig Dis Sci 33 (1988) 1057-1063
9. Yamagata S., and Hisamichi S. Precancerous lesions of the stomach. World J Surg 3 (1979) 671-673
10. Hansson L.E., Nyren O., Hsing A.W., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335 (1996) 242-249
11. Hopper A.N., Stephens M.R., Lewis W.G., et al. Relative value of repeat gastric ulcer surveillance gastroscopy in diagnosing gastric cancer. Gastric Cancer 9 (2006) 217-222
12. Saini S.D., Eisen G., Mattek N., et al. Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol 103 (2008) 1920-1925
13. Hosokawa O., Tsuda S., Kidani E., et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 30 (1998) 669-674
14. Guarner J., Herrera-Goepfert R., Mohar A., et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol 34 (2003) 28-31
15. Schauer P.R., Schwesinger W.H., Page C.P., et al. Complications of surgical endoscopy: a decade of experience from a surgical residency training program. Surg Endosc 11 (1997) 8-11
16. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications: results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA 235 (1976) 928-930
17. Finlayson E.V., and Birkmeyer J.D. Operative mortality with elective surgery in older adults. Eff Clin Pract 4 (2001) 172-177
18. Arias E. United States life tables, 2000. Natl Vital Stat Rep 51 (2002) 1-38
19. U.S. Department of Health and Human Services, Center for Medicare & Medicaid Services. Fee Schedule (2007). http://www.cms.hhs.gov Accessed July 20, 2008
20. Yabroff K.R., Lamont E.B., Mariotto A., et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 100 (2008) 630-641
21. Bureau of Labor Statistics, U.S. Department of Labor. Occupational Employment and Wages (2007). http:/stat.bls.gov/oes/home.htm Accessed August 18, 2008
22. Yabroff K.R., Davis W.W., Lamont E.B., et al. Patient time costs associated with cancer care. J Natl Cancer Inst 99 (2007) 14-23
23. Hanmer J., Lawrence W.F., Anderson J.P., et al. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 26 (2006) 391-400
24. Gold M.R., Franks P., McCoy K.I., et al. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36 (1998) 778-792
25. In: Gold M.R., Siegel J.E., Russel L.B., et al. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York (NY)
26. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
27. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
28. Briggs A.H., Goeree R., Blackhouse G., et al. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 22 (2002) 290-308
29. Breslin N.P., and Sutherland L.R. Survey of current practices among members of CAG in the follow-up of patients diagnosed with gastric ulcer. Can J Gastroenterol 13 (1999) 489-493
30. Neumann P.J., Sandberg E.A., Bell C.M., et al. Are pharmaceuticals cost-effective?. a review of the evidence. Health Aff (Millwood) 19 (2000) 92-109
31. Graham D.Y., Schwartz J.T., Cain G.D., et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 82 (1982) 228-231
32. Wong B.C., Lam S.K., Wong W.M., et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291 (2004) 187-194
33. Fukase K., Kato M., Kikuchi S., et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372 (2008) 392-397
34. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044